Target intelligence / Profile preview

Nephron progenitor cell (NPC)

Target
NPC
Molecular classification
Other (Progenitor cell, Stem cell)
01

Overview

Nephron progenitor cells are a population of kidney-specific stem/progenitor cells essential for kidney development and nephron formation. These cells, marked by expression of SIX2 and NCAM1, are capable of self-renewal and differentiation into all epithelial components of the nephron. While in humans they are naturally present during development and lost before or shortly after birth, recent advances in stem cell technology have enabled the derivation of NPCs from induced pluripotent stem cells for research and therapeutic purposes. Engraftment of NPCs into injured or developing kidneys in animal models has demonstrated their ability to integrate, differentiate, and promote regeneration of kidney structures[2][4][5][3][6]. Cell-based therapies using nephron progenitor cells (human or engineered) are under investigation for the treatment of acute and chronic kidney diseases, offering potential for kidney repair through targeted regeneration and functional restoration.

Other names
Renal progenitor cellKidney progenitor cellHuman nephron progenitor cell (hNPC)Induced pluripotent stem cell–derived nephron progenitor cell (iPSC-NPC)SIX2-positive cap mesenchymal cell
02

Mechanism of action

Engraftment and differentiation into nephron structures Secretion of trophic factors (e.g., VEGF-A) promoting repair and neovascularization[5] Direct replacement of damaged renal epithelial cells

03

Biological functions

Kidney developmentCell differentiationCell self-renewalNephron formationTissue regeneration
04

Disease associations

Chronic kidney diseaseAcute kidney injuryOther kidney diseases
05

Safety considerations

Risk of immune rejection (especially xenogeneic or allogeneic cell sources)[3][6]Tumorigenicity if cell populations are not fully differentiatedLong-term viability and integrationPotential for aberrant differentiationRequirement for immunosuppression or genetic manipulation[3][6]
06

Biomarkers

SIX2 (transcription factor)NCAM1 (neural cell adhesion molecule 1)[2]VIM (Vimentin)Low CDH1/E-Cadherin (early progenitor state)[2]

Beyond the preview

Go deeper on Nephron progenitor cell (NPC).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Nephron progenitor cell (NPC).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call